In Vitro Strategies to Vascularize 3D Physiologically Relevant Models

Abstract Vascularization of 3D models represents a major challenge of tissue engineering and a key prerequisite for their clinical and industrial application. The use of prevascularized models built from dedicated materials could solve some of the actual limitations, such as suboptimal integration o...

Full description

Bibliographic Details
Main Authors: Alessandra Dellaquila, Chau Le Bao, Didier Letourneur, Teresa Simon‐Yarza
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202100798
id doaj-2ccaecc2df2a44b98b461bb8432b67d5
record_format Article
spelling doaj-2ccaecc2df2a44b98b461bb8432b67d52021-10-08T09:03:05ZengWileyAdvanced Science2198-38442021-10-01819n/an/a10.1002/advs.202100798In Vitro Strategies to Vascularize 3D Physiologically Relevant ModelsAlessandra Dellaquila0Chau Le Bao1Didier Letourneur2Teresa Simon‐Yarza3Université de Paris INSERM U1148 X Bichat Hospital Paris F‐75018 FranceUniversité de Paris INSERM U1148 X Bichat Hospital Paris F‐75018 FranceUniversité de Paris INSERM U1148 X Bichat Hospital Paris F‐75018 FranceUniversité de Paris INSERM U1148 X Bichat Hospital Paris F‐75018 FranceAbstract Vascularization of 3D models represents a major challenge of tissue engineering and a key prerequisite for their clinical and industrial application. The use of prevascularized models built from dedicated materials could solve some of the actual limitations, such as suboptimal integration of the bioconstructs within the host tissue, and would provide more in vivo‐like perfusable tissue and organ‐specific platforms. In the last decade, the fabrication of vascularized physiologically relevant 3D constructs has been attempted by numerous tissue engineering strategies, which are classified here in microfluidic technology, 3D coculture models, namely, spheroids and organoids, and biofabrication. In this review, the recent advancements in prevascularization techniques and the increasing use of natural and synthetic materials to build physiological organ‐specific models are discussed. Current drawbacks of each technology, future perspectives, and translation of vascularized tissue constructs toward clinics, pharmaceutical field, and industry are also presented. By combining complementary strategies, these models are envisioned to be successfully used for regenerative medicine and drug development in a near future.https://doi.org/10.1002/advs.2021007983D cell culturebioprintingmicrofluidicstissue engineeringvascularization
collection DOAJ
language English
format Article
sources DOAJ
author Alessandra Dellaquila
Chau Le Bao
Didier Letourneur
Teresa Simon‐Yarza
spellingShingle Alessandra Dellaquila
Chau Le Bao
Didier Letourneur
Teresa Simon‐Yarza
In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
Advanced Science
3D cell culture
bioprinting
microfluidics
tissue engineering
vascularization
author_facet Alessandra Dellaquila
Chau Le Bao
Didier Letourneur
Teresa Simon‐Yarza
author_sort Alessandra Dellaquila
title In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
title_short In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
title_full In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
title_fullStr In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
title_full_unstemmed In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
title_sort in vitro strategies to vascularize 3d physiologically relevant models
publisher Wiley
series Advanced Science
issn 2198-3844
publishDate 2021-10-01
description Abstract Vascularization of 3D models represents a major challenge of tissue engineering and a key prerequisite for their clinical and industrial application. The use of prevascularized models built from dedicated materials could solve some of the actual limitations, such as suboptimal integration of the bioconstructs within the host tissue, and would provide more in vivo‐like perfusable tissue and organ‐specific platforms. In the last decade, the fabrication of vascularized physiologically relevant 3D constructs has been attempted by numerous tissue engineering strategies, which are classified here in microfluidic technology, 3D coculture models, namely, spheroids and organoids, and biofabrication. In this review, the recent advancements in prevascularization techniques and the increasing use of natural and synthetic materials to build physiological organ‐specific models are discussed. Current drawbacks of each technology, future perspectives, and translation of vascularized tissue constructs toward clinics, pharmaceutical field, and industry are also presented. By combining complementary strategies, these models are envisioned to be successfully used for regenerative medicine and drug development in a near future.
topic 3D cell culture
bioprinting
microfluidics
tissue engineering
vascularization
url https://doi.org/10.1002/advs.202100798
work_keys_str_mv AT alessandradellaquila invitrostrategiestovascularize3dphysiologicallyrelevantmodels
AT chaulebao invitrostrategiestovascularize3dphysiologicallyrelevantmodels
AT didierletourneur invitrostrategiestovascularize3dphysiologicallyrelevantmodels
AT teresasimonyarza invitrostrategiestovascularize3dphysiologicallyrelevantmodels
_version_ 1716838566945882112